MAPT and Alzheimer disease: In summary, current available evidence from in vitro, animal and human case reports support the notion that Aβ and tau pathologies can be transmitted in vivo, similar to what has been observed in prion diseases, suggesting that, at least in some instances, AD may potentially be a transmissible disorder.